Interestingly, pharmacological treatment with anakinra restored MeCP2 expression and cognitive deficits in IL-1R8-deficient mice, highlighting that the inhibition of IL-1 signaling may be efficacious for treating neurological diseases through immune system modulation [4,185]. The gene discussed is IL1A; the disease is Cognitive impairment.